XML 43 R7.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2019
Oct. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (40,896) [1] $ (40,196) [2] $ (113,958) [1] $ (114,918) [2]
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation and amortization 16,038 [1] 11,433 [2] 42,102 [1] 34,677 [2]
Stock-based compensation expense 37,758 [1] 31,790 [2] 106,925 [1] 89,086 [2]
Amortization of deferred commissions 6,650 [1] 4,516 [2] 18,360 [1] 12,231 [2]
Loss (gain) on disposal of property and equipment   586 [2] (2) [1] 586 [2]
Others 7 [1] (18) [2] (113) [1] (13) [2]
Changes in operating assets and liabilities:        
Accounts receivable, net 9,510 [1] 9,065 [2] 66,737 [1] 57,001 [2]
Deferred commissions (11,617) [1] (9,753) [2] (26,571) [1] (23,057) [2]
Prepaid expenses and other assets 1,550 [1] 350 [2] (3,289) [1] (4,583) [2]
Operating lease right-of-use assets, net [1] 9,007   26,445  
Accounts payable (7,486) [1] 959 [2] (4,201) [1] (246) [2]
Accrued expenses and other liabilities 919 [1] (1,640) [2] (8,392) [1] (16,907) [2]
Operating lease liabilities [1] (7,360)   (24,950)  
Deferred revenue (5,187) [1] (276) [2] (49,394) [1] (9,868) [2]
Net cash provided by operating activities 8,893 [1] 6,816 [2] 29,699 [1] 23,989 [2]
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchases of property and equipment (1,055) [1] (5,247) [2] (4,221) [1] (12,613) [2]
Capitalized internal-use software costs (2,469) [1] (1,343) [2] (6,482) [1] (1,343) [2]
Proceeds from sales of property and equipment   1 [2] 6 [1] 2 [2]
Acquisitions [2]       (458)
Net cash used in investing activities (3,524) [1] (6,589) [2] (10,697) [1] (14,412) [2]
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from exercise of stock options 764 [1] 2,145 [2] 3,008 [1] 14,976 [2]
Proceeds from issuances of common stock under employee stock purchase plan 9,820 [1] 10,015 [2] 23,425 [1] 21,861 [2]
Employee payroll taxes paid related to net share settlement of restricted stock units (9,494) [1] (11,596) [2] (35,055) [1] (36,901) [2]
Principal payments of finance lease liabilities (7,055) [1] (4,290) [2] (26,200) [1] (17,192) [2]
Acquisition related contingent consideration [1]     (936)  
Net cash used in financing activities (5,965) [1] (3,726) [2] (35,758) [1] (17,256) [2]
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (3) [1] (123) [2] (110) [1] (405) [2]
Net decrease in cash, cash equivalents, and restricted cash (599) [1] (3,622) [2] (16,866) [1] (8,084) [2]
Cash, cash equivalents, and restricted cash, beginning of period 201,489 [1] 203,964 [2] 217,756 [1] 208,426 [2]
Cash, cash equivalents, and restricted cash, end of period 200,890 [1] 200,342 [2] 200,890 [1] 200,342 [2]
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Cash paid for interest 1,258 [1] 623 [2] 3,768 [1] 1,795 [2]
Cash paid for income taxes, net of tax refunds 967 [1] 501 [2] 2,718 [1] 1,493 [2]
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:        
Accrued equipment purchases 3,835 [1] 10,560 [2] 4,012 [1] 11,151 [2]
Increase in long-lived assets resulting from capitalizing asset retirement costs     2,717 [1] 566 [2]
Stock-based compensation capitalized in internal-use software costs [1] 1,188   3,626  
Increase in finance lease liabilities 40,530 [1],[3] 9,230 [2] 84,950 [1],[3] 27,751 [2]
Issuance of common stock in connection with acquisitions [2]       1,053
Contingent consideration accruals in connection with acquisitions [2]       936
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH INFORMATION:        
Cash and cash equivalents, beginning of period 201,489 [1] 203,726 [2] 217,518 [1],[2] 208,076 [2]
Restricted cash, beginning of period   238 [2] 238 [1] 350 [2]
Cash, cash equivalents, and restricted cash, beginning of period 201,489 [1] 203,964 [2] 217,756 [1] 208,426 [2]
Cash and cash equivalents, end of period 200,890 [1] 200,104 [2] 200,890 [1] 200,104 [2]
Restricted cash, end of period [2]   238   238
Cash, cash equivalents, and restricted cash, end of period $ 200,890 [1] $ 200,342 [2] $ 200,890 [1] $ 200,342 [2]
[1] As reported and disclosed under ASC Topic 842
[2] As reported and disclosed under ASC Topic 840
[3] Includes the adoption impact of ASC Topic 842 on the opening balance sheet as of February 1, 2019 as disclosed in Note 1.